He aha ʻo Crizanlizumab: Nā Hoʻohana, Nā Kumu, Nā ʻAoʻao ʻAoʻao a me nā mea hou aku

He lāʻau lapaʻau ʻo Crizanlizumab i hoʻolālā ʻia e kōkua i ka poʻe me ka maʻi ʻana o ke kelepona e hōʻemi i kā lākou pilikia ʻeha. Hāʻawi ʻia ma o ka IV infusion ma kahi hale mālama ola, maʻamau i hoʻokahi manawa i ka mahina, a hana ma ka pale ʻana i nā cell koko mai ka pili ʻana i loko o kou mau kīʻaha koko.

Hōʻike kēia lapaʻau i kahi hana nui i mua no nā maʻi kelepona e ʻike nei i nā manawa ʻeha pinepine. Ma ka pale ʻana i kahi protein kikoʻī e hoʻoulu ai i nā cell koko e hui pū, hiki i ka crizanlizumab ke kōkua iā ʻoe e loaʻa i nā pilikia ʻeha liʻiliʻi a hoʻomaikaʻi i kou ola.

He aha ʻo Crizanlizumab?

ʻO Crizanlizumab kahi lāʻau lapaʻau monoclonal antibody e kuhikuhi ana i kahi protein i kapa ʻia ʻo P-selectin i loko o kou mau kīʻaha koko. E noʻonoʻo i ka P-selectin ma ke ʻano he ʻili paʻa e hoʻoulu ai i nā cell koko e hui pū, hiki ke ālai i ke kahe koko a hoʻoulu i ka ʻeha nui e pili ana me nā pilikia kelepona.

Hana ʻia ka lāʻau lapaʻau ma lalo o ka inoa inoa Adakveo a no ka papa o nā lāʻau i kapa ʻia he selectin blockers. Ua hoʻolālā kūikawā ʻia e ʻike a paʻa i ka P-selectin, e uhi ana i kēia mau wahi paʻa i hiki i nā cell koko ke kahe manuahi ma waena o kou mau kīʻaha.

Ua manaʻo ʻia he lāʻau lapaʻau kūikawā kēia no ka mea e pono ai ka nānā pono ʻana a me ka lawelawe ʻana i kahi hoʻonohonoho lapaʻau. E hana paʻa kāu hui mālama ola me ʻoe e hoʻoholo inā ʻo crizanlizumab ke koho kūpono no kāu kūlana.

No ke aha e hoʻohana ʻia ai ʻo Crizanlizumab?

Hoʻohana nui ʻia ʻo Crizanlizumab e hōʻemi i ke alapine o nā pilikia vaso-occlusive ʻeha i ka poʻe me ka maʻi kelepona. Hiki mai kēia mau pilikia i ka wā e ālai ai nā cell koko maʻi i nā kīʻaha koko, e hoʻoulu ana i ka ʻeha nui e hiki ke mau no nā hola a i ʻole nā lā.

Ua ʻae ʻia ka lāʻau lapaʻau no nā mākua a me nā keiki 16 makahiki a ʻoi aku ka nui e ʻike nei i nā pilikia ʻeha pinepine. ʻAʻole pono ʻoe e loaʻa i kahi helu kikoʻī o nā pilikia i kēlā me kēia makahiki e kūpono ai, akā e noʻonoʻo kāu kauka i kāu mōʻaukala ʻeha pilikino a me ke olakino holoʻokoʻa i ka wā e hoʻoholo ai inā kūpono kēia lapaʻau.

ʻOiai hiki i ka crizanlizumab ke hōʻemi nui i ke alapine o ka pilikia, he mea nui e hoʻomaopopo ʻaʻole paha ia e hoʻopau i nā hanana ʻeha a pau. ʻIke ka hapa nui o nā kānaka i kekahi mau pilikia, akā ʻoi aku ka liʻiliʻi o lākou a i kekahi manawa ʻaʻole ʻoi aku ka paʻakikī ma mua o ka lapaʻau.

Pehea e hana ai ʻo Crizanlizumab?

Hana ʻo Crizanlizumab ma ka pale ʻana i ka P-selectin, kahi protein e hana ana e like me ka velcro molekala ma loko o kou mau kīʻaha koko. Ke hana ʻo P-selectin, e hoʻopili ia i nā cell koko, nā platelets, a me nā mea ʻē aʻe i nā paia o nā kīʻaha koko a me kekahi i kekahi.

I ka maʻi cell sickle, he pilikia nui kēia hana pili no ka mea ua hewa mua kou mau cell koko ʻulaʻula a maʻa mau e paʻa maʻalahi. Ma ka pale ʻana i ka P-selectin, kōkua ʻo crizanlizumab i ka pale ʻana i kēia kaʻa cellular mai ka hana ʻana i ka wahi mua.

Ua manaʻo ʻia he lāʻau lapaʻau ikaika i ka hana i manaʻo ʻia, akā hana mālie i ka manawa ma mua o ka hāʻawi ʻana i ka hoʻomaha koke. Kūkulu mālie nā hopena, ʻo ia ke kumu e pono ai ʻoe i nā infusions he nui ma mua o ka ʻike ʻana i nā pōmaikaʻi piha.

Pehea wau e lawe ai iā Crizanlizumab?

Hāʻawi ʻia ʻo Crizanlizumab ma ke ʻano he infusion intravenous ma kahi o 30 mau minuke i loko o kahi keʻena mālama ola. E loaʻa iā ʻoe ka lāʻau lapaʻau i hoʻokahi manawa i kēlā me kēia ʻehā pule, a e nānā kāu hui mālama ola iā ʻoe i ka wā a ma hope o kēlā me kēia infusion.

Ma mua o kāu infusion, hāʻawi ʻia ʻoe i nā lāʻau lapaʻau e kōkua i ka pale ʻana i nā hopena maʻi. Hiki i kēia mau mea ke komo i nā antihistamines, acetaminophen, a i ʻole corticosteroids. E haʻi aku kāu kauka iā ʻoe inā pono ʻoe i kēia mau lāʻau lapaʻau.

ʻAʻole pono ʻoe e ʻai wikiwiki ma mua o ka mālama ʻana, a hiki iā ʻoe ke ʻai maʻamau i nā lā hoʻokomo. Eia naʻe, he manaʻo maikaʻi e noho maikaʻi i ka wai ma ka inu ʻana i ka wai nui ma mua a ma hope o kāu manawa. Manaʻo kekahi poʻe he mea kōkua ke lawe mai i kahi mea ʻai a me kekahi mea e mālama iā lākou i ka wā o ka hoʻokomo ʻana.

Pehea ka lōʻihi e lawe ai au i ka Crizanlizumab?

ʻO Crizanlizumab ka mea maʻamau he lapaʻau lōʻihi e hoʻomau ai ʻoe i ka wā e kōkua ana e hōʻemi i kāu pilikia ʻeha a ʻaʻole ʻoe e ʻike i nā hopena ʻaoʻao pilikia. Noho ka hapa nui o nā kānaka i ka lāʻau lapaʻau no nā mahina a i ʻole nā ​​makahiki.

E loiloi mau kāu kauka i ka maikaʻi o ka hana ʻana o ka lāʻau lapaʻau iā ʻoe, ma hope o nā mahina mua o ka mālama ʻana. E nānā lākou i ka nui o nā pilikia ʻeha āu e loaʻa nei i ka hoʻohālikelike ʻana i mua o ka hoʻomaka ʻana i ka crizanlizumab a nānā i nā hopena ʻaoʻao.

E hilinaʻi ka hoʻoholo e hoʻomau a hoʻōki paha i ka mālama ʻana i kāu pane pilikino a me nā loli i kou olakino holoʻokoʻa. Pono paha kekahi poʻe e hoʻomaha i ka mālama ʻana no ka manawa pōkole inā loaʻa iā lākou nā maʻi a i ʻole nā ​​pilikia olakino ʻē aʻe, akā hiki i ka nui ke hoʻomau i ka wā e maikaʻi ai lākou.

He aha nā hopena ʻaoʻao o Crizanlizumab?

E like me nā lāʻau lapaʻau a pau, hiki i ka crizanlizumab ke hoʻoulu i nā hopena ʻaoʻao, ʻoiai he nui ka poʻe e ʻae maikaʻi iā ia. ʻO nā hopena ʻaoʻao maʻamau he maʻalahi a hiki ke mālama ʻia me ke kākoʻo olakino kūpono.

Eia nā hopena ʻaoʻao āu e ʻike ai, me ka noʻonoʻo ʻana ʻaʻole e loaʻa i nā mea a pau kēia mau hopena:

ʻO nā hopena ʻaoʻao maʻamau e pili ana:

• Ka maʻi a me ka ʻoluʻolu o ka ʻōpū
• ʻEha hui a i ʻole arthralgia
• ʻEha hope
• Fiva
• Nā hopena e pili ana i ka hoʻokomo ʻana e like me ka ʻulaʻula a i ʻole nā ​​hōʻailona maʻi maʻi maʻalahi

ʻO nā hopena ʻaoʻao liʻiliʻi akā ʻoi aku ka koʻikoʻi e pili ana:

• Nā hopena maʻi koʻikoʻi i ka wā a i ʻole ma hope o ka hoʻokomo ʻana
• Hoʻonui ʻia ka pilikia o nā maʻi
• Nā loli nui i ke koko
• Ke kahe ʻana o ke koko a i ʻole ka ʻeha ʻana

Nā pilikia liʻiliʻi akā koʻikoʻi e komo pū ana:

• Anaphylaxis (hopena maʻi koʻikoʻi)
• Nā maʻi koʻikoʻi e pono ai ka haukapila
• Hoʻopilikia i ka hana platelet e alakaʻi ana i nā pilikia kahe koko

E nānā pono kāu hui mālama ola iā ʻoe i ka wā o kēlā me kēia hoʻokomo ʻana a e aʻo lākou iā ʻoe i nā hōʻailona e makaʻala ai ma ka home. Hiki ke mālama ʻia ka hapa nui o nā hopena ʻaoʻao, a ʻoi aku ka maikaʻi o ka hōʻemi ʻana i nā pilikia ʻeha no nā mea maʻi he nui.

ʻO wai ka mea ʻaʻole pono e lawe iā Crizanlizumab?

ʻAʻole kūpono ʻo Crizanlizumab no nā mea a pau, a e loiloi pono kāu kauka inā palekana ia no ʻoe e pili ana i kāu mōʻaukala olakino a me ke kūlana olakino o kēia manawa.

ʻAʻole pono ʻoe e loaʻa iā crizanlizumab inā he maʻi koʻikoʻi ʻoe i ka lāʻau lapaʻau a i ʻole kekahi o kāna mau mea. E akahele nō hoʻi kāu kauka inā he mōʻaukala kou o nā hopena maʻi koʻikoʻi i nā lāʻau lapaʻau antibody monoclonal ʻē aʻe.

Pono paha ka poʻe me nā maʻi koʻikoʻi e kali a hiki i ka mālama ʻia ʻana o ka maʻi ma mua o ka hoʻomaka ʻana iā crizanlizumab. Hiki i ka lāʻau lapaʻau ke hoʻopilikia i ka hiki o kāu ʻōnaehana pale e hakakā i nā maʻi, no laila he mea nui ka manawa.

Pono nā wahine hāpai a me nā wahine e hānai ana i ka waiū e kūkākūkā pono i nā pilikia a me nā pōmaikaʻi me kā lākou mea mālama ola, no ka mea, he palena nā ʻikepili palekana no kēia mau kūlana. E kaupaona kāu kauka i nā pōmaikaʻi e hiki mai ana e kūʻē i nā pilikia e hiki mai ana iā ʻoe a me kāu pēpē.

Crizanlizumab Brand Name

Hoʻolaha ʻia ʻo Crizanlizumab ma lalo o ka inoa brand Adakveo e Novartis Pharmaceuticals. ʻO kēia wale nō ka inoa brand i loaʻa no kēia lāʻau lapaʻau ma ʻAmelika Hui Pū ʻIa.

I ka wā e loaʻa ai iā ʻoe kāu lapaʻau, e ʻike ʻoe iā Adakveo ma ka lepili lāʻau a me kāu moʻolelo olakino. ʻAʻohe mana generic o crizanlizumab i loaʻa i kēia manawa, no ka mea, he lāʻau lapaʻau hou ia e pale ʻia nei e ka palapala Sila Nui.

E pili ana kāu ʻinikua a me nā koi ʻae mua i ka inoa generic (crizanlizumab) a me ka inoa brand (Adakveo) i kā lākou palapala.

Nā Koho ʻē aʻe o Crizanlizumab

ʻOiai he mea kū hoʻokahi ʻo crizanlizumab i kāna hana, aia nā lāʻau lapaʻau ʻē aʻe e kōkua i ka mālama ʻana i ka maʻi sickle cell a me ka hōʻemi ʻana i nā pilikia ʻeha. Hiki i kāu kauka ke noʻonoʻo i kēia mau koho ʻē aʻe inā ʻaʻole kūpono ʻo crizanlizumab iā ʻoe.

ʻO Hydroxyurea ka lāʻau lapaʻau mua no ka pale ʻana i nā pilikia sickle cell. Hana ʻokoʻa ia ma mua o crizanlizumab ma ka hoʻonui ʻana i ka hana ʻana o ka fetal hemoglobin, e kōkua ana i ka pale ʻana i nā ʻulaʻula koko mai ka maʻi ʻana.

ʻO Voxelotor (Oxbryta) kekahi lāʻau lapaʻau hou e hana ana ma ka hoʻonui ʻana i ka pili ʻana o ka hemoglobin i ka oxygen, e kōkua ana i ka pale ʻana i ka maʻi. ʻO L-glutamine (Endari) he mea hoʻohui amino acid e hiki ke kōkua i ka hōʻemi ʻana i ke alapine pilikia ma o nā ʻano hana like ʻole.

Hiki i kāu kauka ke ʻōlelo aku i ka lāʻau hui pū, me ka hoʻohana ʻana iā crizanlizumab me hydroxyurea a i ʻole nā ​​lāʻau lapaʻau ʻē aʻe. Aia ke koho i kāu mau hōʻailona kikoʻī, ka mōʻaukala olakino, a me ka maikaʻi o kāu pane ʻana i nā lāʻau lapaʻau mua.

ʻOi aku ka maikaʻi o Crizanlizumab ma mua o Hydroxyurea?

Hana ʻo Crizanlizumab a me hydroxyurea ma o nā ʻano hana like ʻole, no laila ʻaʻole maʻalahi ka hoʻohālikelike ʻana iā lākou. Hiki i nā mea ʻelua ke maikaʻi i ka hōʻemi ʻana i nā pilikia ʻeha, akā hiki iā lākou ke hana maikaʻi no nā poʻe like ʻole a i ʻole i nā kūlana like ʻole.

Ua hoʻohana ʻia ʻo Hydroxyurea no nā makahiki he nui a he palekana maikaʻi, ʻoiai ʻo crizanlizumab he mea hou me ka liʻiliʻi o ka ʻikepili lōʻihi. Eia naʻe, hiki i kekahi poʻe i pane ʻole i ka hydroxyurea ke loaʻa ka pōmaikaʻi nui mai crizanlizumab.

Nui nā kauka e hoʻohana maoli i kēia mau lāʻau lapaʻau me kekahi, ma mua o ke koho ʻana i kekahi ma luna o kekahi. Hiki i ke ala hui ke hāʻawi i ka pale ʻana i ka pilikia ma mua o kekahi lāʻau lapaʻau wale nō. E noʻonoʻo kāu kauka i kāu mōʻaukala olakino pilikino, nā pane lapaʻau mua, a me nā makemake pilikino i ka wā e hana ai i nā ʻōlelo paipai.

Nā Nīnau i Nīnau pinepine ʻia e pili ana iā Crizanlizumab

Q1. Palekana anei ʻo Crizanlizumab no ka poʻe me ka maʻi kīkī?

Hiki ke hoʻohana palekana ʻia ʻo Crizanlizumab i ka poʻe me ka maʻi kīkī maʻalahi a i ka maʻi kīkī, akā e nānā pono kāu kauka iā ʻoe inā he pilikia kou kīkī. ʻAʻole hoʻopau mua ʻia ka lāʻau lapaʻau ma nā kīkī, no laila ʻaʻole pono e hoʻoponopono i ka dosis.

Eia naʻe, ʻo ka poʻe me ka maʻi cell sickle e hoʻomohala pinepine i nā pilikia kīkī i ka manawa, no laila e makemake kāu kauka e nānā mau i kāu hana kīkī me ka nānā ʻole inā ʻoe ma crizanlizumab. Hiki iā lākou ke kauoha i nā hoʻokolohua koko pinepine e hōʻoia i ka hana maikaʻi ʻana o kou mau kīkī.

Q2. He aha kaʻu e hana ai inā loaʻa iaʻu ka nui o ka Crizanlizumab?

No ka mea, hāʻawi ʻia ʻo crizanlizumab i kahi hoʻonohonoho mālama ola, he kakaikahi loa nā overdoses. Ana ʻia ka lāʻau lapaʻau a mālama ʻia e nā poʻe loea mālama ola i aʻo ʻia e hahai i nā protocols koʻikoʻi.

Inā hopohopo ʻoe e pili ana i kāu dosis a i ʻole e ʻike i nā hōʻailona maʻamau ma hope o ka infusion, e hoʻokaʻaʻike koke i kāu mea mālama ola. Hiki iā lākou ke loiloi i kāu mau hōʻailona a hāʻawi i ka mālama kūpono inā pono. E nānā pū ka infusion center iā ʻoe no nā hōʻailona o nā hopena ʻino i ka wā a ma hope o ka mālama ʻana.

Q3. He aha kaʻu e hana ai inā haʻalele au i kahi dosis o Crizanlizumab?

Inā ʻoe e hala i kāu manawa hoʻopaʻa ʻia no ka hoʻokomo ʻana, e kelepona i kāu mea mālama ola i ka hiki wawe e hoʻopaʻa hou. He mea nui e mālama i kāu papa hana lapaʻau maʻamau e mālama pono ai ka lāʻau lapaʻau.

Ma keʻano maʻamau, inā he mau lā wale nō ʻoe i hala, hiki iā ʻoe ke loaʻa kāu hoʻokomo ʻana a laila e hoʻomau me kāu papa hana mahina maʻamau. Eia naʻe, inā ua hala ʻoe i nā lāʻau he nui, pono paha i kāu kauka e hoʻoponopono i kāu hoʻolālā lapaʻau a i ʻole e nānā pono iā ʻoe ke hoʻomaka hou ʻoe.

Q4. I ka manawa hea e hiki ai iaʻu ke hooki i ka lawe ʻana iā Crizanlizumab?

ʻO ka hoʻoholo e hooki i ka crizanlizumab e hana mau ʻia ma ke kūkākūkā ʻana me kāu mea mālama ola. ʻAʻole pono ʻoe e hooki i ka lapaʻau ma kāu iho, ʻoiai inā ʻoe e manaʻo maikaʻi a ʻaʻole i loaʻa nā pilikia ʻeha i kēia manawa.

E loiloi mau kāu kauka inā he pono ka lapaʻau iā ʻoe, maʻamau i kēlā me kēia mau mahina. E noʻonoʻo lākou i nā mea e like me ka nui o nā pilikia ʻeha āu e loaʻa nei, nā hopena ʻaoʻao āu e ʻike nei, a me nā loli i kou kūlana olakino holoʻokoʻa.

Q5. Hiki iaʻu ke loaʻa nā lāʻau lapaʻau i ka wā e lawe ana iā Crizanlizumab?

He palekana ka hapa nui o nā lāʻau lapaʻau e loaʻa i ka wā e lawe ana iā crizanlizumab, akā pono ʻoe e kūkākūkā mau i nā lāʻau lapaʻau e hiki mai ana me kāu mea mālama ola mua. Hiki iā lākou ke ʻōlelo i ka manawa o nā lāʻau lapaʻau ma waena o nā hoʻokomo ʻana a i ʻole e nānā pono iā ʻoe ma hope o ka lāʻau lapaʻau.

Pono paha nā lāʻau lapaʻau ola i ka noʻonoʻo kūikawā, no ka mea, hiki i ka crizanlizumab ke hoʻopilikia i kāu pane ʻana i ka pale. E nānā kāu kauka i kāu mōʻaukala lāʻau lapaʻau a me nā pono o kēia manawa e hōʻoia ai e noho palekana ʻoe mai nā maʻi hiki ke pale ʻia i ka wā e mālama ʻia ai.